Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13209006 | 1.00 | TSHR (0.45) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 | |
| SCHEMBL13209005 | 1.00 | TSHR (0.45) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 | |
| SCHEMBL12470124 | 0.83 | SMN1; SMN2 (0.43) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 | |
| SCHEMBL28788465 | 0.83 | SMN1; SMN2 (0.40) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 | |
| SCHEMBL10575336 | 0.81 | FPR2 (0.49) | TSHRSMN1; SMN2NAALAD2MAPTFPR2 | |
| SCHEMBL10575333 | 0.81 | FPR2 (0.49) | TSHRSMN1; SMN2NAALAD2MAPTFPR2 | |
| SCHEMBL1133141 | 0.80 | NAALAD2 (0.39) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 | |
| SCHEMBL1133243 | 0.80 | NAALAD2 (0.39) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 | |
| SCHEMBL1133246 | 0.80 | NAALAD2 (0.39) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 | |
| SCHEMBL5607969 | 0.79 | NAALAD2 (0.47) | TSHRSMN1; SMN2NAALAD2KDM4CALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197934-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALPHA-METHYLCYSTEINE DERIVATIVE | KANEKA CORPORATION (JP) | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197934-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALPHA-METHYLCYSTEINE DERIVATIVE | AHCY, CTH, BHMT | TSHR 4129/4885SMN1; SMN2 4472/4885NAALAD2 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.